Metraipolis › archive › dc_079e95bb1096
Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS-CoV-2 — Europe PMC PMID:41316949
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41316949
- DOI
- 10.1002/ardp.70158
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:35:32.605Z
- SHA-256 of the archived text
84aa6ac93214b31b3dcfc740db21d074198deb304a70a5748498becae4fcb8f4- Stable URL of this page
https://metraipolis.com/documento/dc_079e95bb1096
How to cite
Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS-CoV-2 — Europe PMC PMID:41316949 — Europe PMC (en), https://europepmc.org/article/MED/41316949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_079e95bb1096 (Metraipolis archive dc_079e95bb1096, sha256 84aa6ac93214b31b3dcfc740db21d074198deb304a70a5748498becae4fcb8f4)
BibTeX
@misc{dc079e95bb1096,
title = {Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS-CoV-2 — Europe PMC PMID:41316949},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41316949},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_079e95bb1096; sha256 84aa6ac93214b31b3dcfc740db21d074198deb304a70a5748498becae4fcb8f4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41316949. Agents can read the archived copy with the MCP tool read_document.